Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

South African Aids Group Says Treatment Stalling

By R&D Editors | December 3, 2014

Gardeners pass World AIDS Day banners on the perimeter of an office building in Sandton, Johannesburg, South Africa, Monday, Dec. 1, 2014. About 2 million HIV-infected people are on government supplied ARV's with stigma related to the disease being a major issue according to the Treatment Action Campaign (TAC) who fought for the government funded drugs. (AP Photo/Denis Farrell)
In T-shirts boldly declaring “HIV Positive,” members of the Treatment Action Campaign marked the 10th anniversary of their court victory that brought the South African government to provide drugs to AIDS patients, in Johannesburg on Monday.
 
Commemorating World Aids Day, the group called it a reunion rather than a celebration as speaker after speaker remembered how life had changed since 2004 now that 2.7 million HIV-positive South Africans receive free treatment.
 
The group refused to join a much larger gathering organized by the South African government and the National AIDS Council in another part of the country.
 
The TAC, one of the country’s largest AIDS awareness groups, said it would not join a celebration while South Africa’s over-burdened public health care system is eroding progress made in the last decade.
 
“We cannot be a middle-income country and accept that we do not have first class treatment,” said Vuyiseka Dubula, who joined the Campaign when she was diagnosed with HIV more than a decade ago.
 
Speaking at the separate government-led festivity, Deputy President Cyril Ramaphosa, who is also chairman of the National Aids Council, said South Africa had received $54 billion from the Global Fund to improve its health services.
 
More than 6.4 million South Africans are living with HIV and about 400,000 more are infected each year, according to the government. Ramaphosa warned that an estimated 2 million HIV-positive South Africans do not know they are infected with the deadly virus.
 
The Treatment Action Campaign said continuous education and improved primary health care are essential in stopping the spread of the disease.
 
Source: Associated Press

Related Articles Read More >

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope
Has the life science lab market finally hit bottom? CBRE data offers cautious hope
Inside the connected lab: Elemental Machines’ CEO on taming alarms, drift and data chaos
Nature’s 2024 Method of the Year has become $100M market and a lawsuit magnet
New study finds gene that can help repair the heart after failure
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE